HROW
Price
$32.16Alerts
Change
+$2.64 (+8.94%)
Updated
Nov 18 closing price
Capitalization
1.01B
110 days until earnings call
Intraday BUY SELL Signals
RDY
Price
$14.98Alerts
Change
+$0.19 (+1.28%)
Updated
Nov 18, 04:59 PM (EDT)
Capitalization
12.42B
65 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HROW vs RDY

HROW vs RDY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HROW vs. RDY commentary
Nov 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a Hold and RDY is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HROW with price predictions
Nov 18, 2026

Momentum Indicator for HROW turns positive, indicating new upward trend

HROW saw its Momentum Indicator move above the 0 level on November 13, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In 68 of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HROW's RSI Indicator exited the oversold zone, 29 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 56 cases where HROW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Moving Average Convergence Divergence (MACD) for HROW just turned positive on October 20, 2026. Looking at past instances where HROW's MACD turned positive, the stock continued to rise in 35 of 45 cases over the following month. The odds of a continued upward trend are 78%.

HROW moved above its 50-day moving average on November 18, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +10.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where HROW advanced for three days, in 236 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HROW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

HROW broke above its upper Bollinger Band on November 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HROW entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. HROW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: HROW's P/B Ratio (66.319) is slightly higher than the industry average of (6.379). P/E Ratio (-27.162) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.270) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (4.627) is also within normal values, averaging (183.387).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for RDY with price predictions
Nov 18, 2026

RDY's RSI Oscillator drives into overbought territory

The RSI Indicator for RDY moved into overbought territory on November 18, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 28 of 53 cases where RDY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 53%.

The Moving Average Convergence Divergence Histogram (MACD) for RDY turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 28 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

RDY broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on RDY as a result. In 50 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.

Following a +1.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in 160 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.

The Aroon Indicator entered an Uptrend today. In 89 of 247 cases where RDY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 36%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. RDY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.032) is normal, around the industry mean (6.379). P/E Ratio (0.375) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (1.666) is also within normal values, averaging (2.202). Dividend Yield (0.020) settles around the average of (0.062) among similar stocks. P/S Ratio (2.817) is also within normal values, averaging (183.387).

The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 73 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
HROW vs RDY: Fundamental Ratings
HROW
RDY
OUTLOOK RATING
1..100
4390
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
5953
SMR RATING
1..100
9973
PRICE GROWTH RATING
1..100
6139
P/E GROWTH RATING
1..100
1397
SEASONALITY SCORE
1..100
5041

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDY's Valuation (50) in the Pharmaceuticals Generic industry is somewhat better than the same rating for HROW (85) in the Pharmaceuticals Other industry. This means that RDY’s stock grew somewhat faster than HROW’s over the last 12 months.

RDY's Profit vs Risk Rating (53) in the Pharmaceuticals Generic industry is in the same range as HROW (59) in the Pharmaceuticals Other industry. This means that RDY’s stock grew similarly to HROW’s over the last 12 months.

RDY's SMR Rating (73) in the Pharmaceuticals Generic industry is in the same range as HROW (99) in the Pharmaceuticals Other industry. This means that RDY’s stock grew similarly to HROW’s over the last 12 months.

RDY's Price Growth Rating (39) in the Pharmaceuticals Generic industry is in the same range as HROW (61) in the Pharmaceuticals Other industry. This means that RDY’s stock grew similarly to HROW’s over the last 12 months.

HROW's P/E Growth Rating (13) in the Pharmaceuticals Other industry is significantly better than the same rating for RDY (97) in the Pharmaceuticals Generic industry. This means that HROW’s stock grew significantly faster than RDY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HROWRDY
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
58%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
53%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 6 days ago
60%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
57%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
50%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
46%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
50%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
46%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
36%
COMPARISON
Comparison
Nov 19, 2026
Stock price -- (HROW: $29.52 vs. RDY: $14.79)
Brand notoriety: HROW and RDY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HROW: 65% vs. RDY: 48%
Market capitalization -- HROW: $1.01B vs. RDY: $12.42B
HROW [@Pharmaceuticals: Generic] is valued at $1.01B. RDY’s [@Pharmaceuticals: Generic] market capitalization is $12.42B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HROW’s FA Score shows that 1 FA rating(s) are green while RDY’s FA Score has 0 green FA rating(s).

  • HROW’s FA Score: 1 green, 4 red.
  • RDY’s FA Score: 0 green, 5 red.
According to our system of comparison, RDY is a better buy in the long-term than HROW.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HROW’s TA Score shows that 6 TA indicator(s) are bullish while RDY’s TA Score has 3 bullish TA indicator(s).

  • HROW’s TA Score: 6 bullish, 2 bearish.
  • RDY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HROW is a better buy in the short-term than RDY.

Price Growth

HROW (@Pharmaceuticals: Generic) experienced а -2.77% price change this week, while RDY (@Pharmaceuticals: Generic) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.75%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -8.43%.

Reported Earning Dates

HROW is expected to report earnings on Mar 08, 2027.

RDY is expected to report earnings on Jan 22, 2027.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.75% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
Interact to see
Advertisement

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AQST. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AQST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+8.94%
AQST - HROW
35%
Loosely correlated
+2.16%
AMRX - HROW
31%
Poorly correlated
+3.60%
RMTI - HROW
27%
Poorly correlated
-7.72%
TEVA - HROW
27%
Poorly correlated
-0.92%
SIGA - HROW
26%
Poorly correlated
+2.56%
More

RDY and

Correlation & Price change

A.I.dvisor tells us that RDY and VTRS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and VTRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+1.28%
VTRS - RDY
28%
Poorly correlated
-0.83%
ALKS - RDY
28%
Poorly correlated
+3.08%
TEVA - RDY
27%
Poorly correlated
-0.92%
HROW - RDY
26%
Poorly correlated
+8.94%
DERM - RDY
25%
Poorly correlated
-5.38%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
AUD.X0.015700N/A
N/A
Aussie Digital cryptocurrency
REQ.X0.041992-0.000064
-0.15%
Request cryptocurrency
DCR.X10.655739-0.106963
-0.99%
Decred cryptocurrency
PIXEL.X0.003283-0.000078
-2.33%
Pixels cryptocurrency
CLV.X0.001439-0.000076
-5.01%
CLV cryptocurrency